unknown
Stage
About
CureMetrix develops FDA-cleared AI-powered software that detects and localizes breast arterial calcifications on mammograms, enabling additional cardiovascular risk screening during routine breast cancer screening.
Explore CureMetrix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.